{"id":387299,"date":"2020-11-23T22:53:42","date_gmt":"2020-11-24T03:53:42","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387299"},"modified":"2020-11-23T22:53:42","modified_gmt":"2020-11-24T03:53:42","slug":"biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/","title":{"rendered":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW ORLEANS<\/span>, <span class=\"xn-chron\">Nov. 23, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) and KSF partner, the former Attorney General of <span class=\"xn-location\">Louisiana<\/span>, <span class=\"xn-person\">Charles C. Foti, Jr.<\/span>, remind investors that they have only until <b><u><span class=\"xn-chron\">November 24, 2020<\/span><\/u><\/b> to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN), if they purchased the Company&#8217;s securities between <span class=\"xn-chron\">February 28, 2020<\/span> and <span class=\"xn-chron\">August 18, 2020<\/span>, inclusive (the &#8220;Class Period&#8221;).\u00a0 This action is pending in <span class=\"xn-location\">the United States<\/span> District Court for the Northern District of <span class=\"xn-location\">California<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg\" title=\"Kahn Swick &amp; Foti, LLC (&quot;KSF&quot;) - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto\/Kahn Swick &amp; Foti, LLC)\" alt=\"Kahn Swick &amp; Foti, LLC (&quot;KSF&quot;) - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto\/Kahn Swick &amp; Foti, LLC)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>What You May Do<\/p>\n<p>If you purchased securities of BioMarin and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (<a href=\"mailto:lewis.kahn@ksfcounsel.com\" rel=\"nofollow\">lewis.kahn@ksfcounsel.com<\/a>), or visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2991672-1&amp;h=1171180319&amp;u=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-bmrn%2F&amp;a=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-bmrn%2F\" rel=\"nofollow noopener noreferrer\">https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-bmrn\/<\/a> \u00a0to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by <b><u><span class=\"xn-chron\">November 24, 2020<\/span><\/u><\/b>.<\/p>\n<p>About the Lawsuit<\/p>\n<p>BioMarin and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.\u00a0 <\/p>\n<p>The alleged false and misleading statements and omissions include, but are not limited to, that: (i) differences between the Phase 1\/2 and Phase 3 study for its drug candidate, valoctocogene roxaparvovec, limited the reliability of the Phase 1\/2 study to support the drug&#8217;s durability of effect; (ii) as a result, it was foreseeable that the FDA would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result of the foregoing, BioMarin&#8217;s statements were materially false and misleading at all relevant times<\/p>\n<p>The case is <i>Tsantes v. BioMarin Pharmaceutical Inc., et al<\/i>, 20-cv-06719.<\/p>\n<p>About Kahn Swick &amp; Foti, LLC<\/p>\n<p>KSF, whose partners include former <span class=\"xn-location\">Louisiana<\/span> Attorney General <span class=\"xn-person\">Charles C. Foti, Jr.<\/span>, is one of the nation&#8217;s premier boutique securities litigation law firms. KSF serves a variety of clients \u2013 including public institutional investors, hedge funds, money managers and retail investors \u2013 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in <span class=\"xn-location\">New York<\/span>, <span class=\"xn-location\">California<\/span> and <span class=\"xn-location\">Louisiana<\/span>.<\/p>\n<p>To learn more about KSF, you may visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2991672-1&amp;h=2066272937&amp;u=http%3A%2F%2Fwww.ksfcounsel.com%2F&amp;a=www.ksfcounsel.com\" rel=\"nofollow noopener noreferrer\">www.ksfcounsel.com<\/a>. <\/p>\n<p>Contact:<br \/>Kahn Swick &amp; Foti, LLC<br \/><span class=\"xn-person\">Lewis Kahn<\/span>, Managing Partner<br \/><u><a target=\"_blank\" href=\"mailto:lewis.kahn@ksfcounsel.com\" rel=\"nofollow noopener noreferrer\">lewis.kahn@ksfcounsel.com<\/a><br \/><\/u>1-877-515-1850<br \/>1100 Poydras St., Suite 3200<br \/><span class=\"xn-location\">New Orleans, LA<\/span> 70163<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DA01899&amp;sd=2020-11-23\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick--foti-llc-remind-investors-with-losses-in-excess-of-100-000-of-deadline-in-class-action-lawsuit-against-biomarin-pharmaceutical-inc---bmrn-301179388.html\">http:\/\/www.prnewswire.com\/news-releases\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick&#8211;foti-llc-remind-investors-with-losses-in-excess-of-100-000-of-deadline-in-class-action-lawsuit-against-biomarin-pharmaceutical-inc&#8212;bmrn-301179388.html<\/a><\/p>\n<p>SOURCE  Kahn Swick &amp; Foti, LLC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DA01899&amp;Transmission_Id=202011232250PR_NEWS_USPR_____DA01899&amp;DateId=20201123\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW ORLEANS, Nov. 23, 2020 \/PRNewswire\/ &#8212;\u00a0Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN), if they purchased the Company&#8217;s securities between February 28, 2020 and August 18, 2020, inclusive (the &#8220;Class Period&#8221;).\u00a0 This action is pending in the United States District Court for the Northern District of California. What You May Do If you purchased securities of BioMarin and would like to discuss your legal rights and how this case might affect you and your right to recover for your &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387299","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW ORLEANS, Nov. 23, 2020 \/PRNewswire\/ &#8212;\u00a0Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN), if they purchased the Company&#8217;s securities between February 28, 2020 and August 18, 2020, inclusive (the &#8220;Class Period&#8221;).\u00a0 This action is pending in the United States District Court for the Northern District of California. What You May Do If you purchased securities of BioMarin and would like to discuss your legal rights and how this case might affect you and your right to recover for your &hellip; Continue reading &quot;BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T03:53:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN\",\"datePublished\":\"2020-11-24T03:53:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/\"},\"wordCount\":472,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/\",\"name\":\"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"datePublished\":\"2020-11-24T03:53:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/","og_locale":"en_US","og_type":"article","og_title":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","og_description":"PR Newswire NEW ORLEANS, Nov. 23, 2020 \/PRNewswire\/ &#8212;\u00a0Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN), if they purchased the Company&#8217;s securities between February 28, 2020 and August 18, 2020, inclusive (the &#8220;Class Period&#8221;).\u00a0 This action is pending in the United States District Court for the Northern District of California. What You May Do If you purchased securities of BioMarin and would like to discuss your legal rights and how this case might affect you and your right to recover for your &hellip; Continue reading \"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T03:53:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN","datePublished":"2020-11-24T03:53:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/"},"wordCount":472,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/","name":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","datePublished":"2020-11-24T03:53:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick-foti-llc-remind-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-biomari\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick &amp; Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. &#8211; BMRN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387299"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387299\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}